Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Jun 30, 2025. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 58
- +7 vs. Q3 2023
- Portfolio value
- $127.8M
- +$10.1M (+8.6%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 702,298 | $36.0M | 28.2% | −13,999−2.0% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 77,240 | $10.2M | 8.0% | 00.0% | Unchanged | History |
| BDSXBiodesix Inc | COM | 5,348,273 | $9.79M | 7.7% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 240,400 | $7.53M | 5.9% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 169,574 | $6.16M | 4.8% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 188,000 | $5.57M | 4.4% | −2,000−1.1% | Reduced | History |
| QDELQuidelOrtho Corp | COM | 65,203 | $4.81M | 3.8% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 84,200 | $3.70M | 2.9% | 00.0% | Unchanged | History |
| ELUTElutia Inc. | CL A COM | 1,655,184 | $3.58M | 2.8% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 114,700 | $2.66M | 2.1% | +32,000+38.7% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 11,000 | $2.42M | 1.9% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 25,000 | $2.09M | 1.6% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 320,930 | $2.07M | 1.6% | +56,087+21.2% | Added | History |
| SILKSilk Road Medical Inc | COM | 158,094 | $1.94M | 1.5% | +116,800+282.8% | Added | History |
| INBXInhibrx Biosciences, Inc. | COM | 48,448 | $1.84M | 1.4% | −22,000−31.2% | Reduced | History |
| MASIMasimo Corp | COM | 15,280 | $1.79M | 1.4% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 150,000 | $1.68M | 1.3% | 00.0% | Unchanged | History |
| TXG10x Genomics, Inc. | CL A COM | 30,000 | $1.68M | 1.3% | +9,000+42.9% | Added | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $1.62M | 1.3% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.39M | 1.1% | 00.0% | Unchanged | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.35M | 1.1% | 00.0% | Unchanged | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 88,000 | $1.33M | 1.0% | +8,000+10.0% | Added | History |
| AXGNAxogen, Inc. | COM | 173,000 | $1.18M | 0.9% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 210,000 | $1.10M | 0.9% | +125,000+147.1% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 48,000 | $1.10M | 0.9% | +10,000+26.3% | Added | History |
| TVTXTravere Therapeutics, Inc. | COM | 122,000 | $1.10M | 0.9% | +40,000+48.8% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 18,000 | $1.08M | 0.8% | 00.0% | Unchanged | History |
| AXDXAccelerate Diagnostics, Inc | COM | 225,239 | $882.9K | 0.7% | 00.0% | Unchanged | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $854.5K | 0.7% | 00.0% | Unchanged | History |
| DCGODocGo Inc. | COM | 150,000 | $838.5K | 0.7% | +20,000+15.4% | Added | History |
| PGNYProgyny, Inc. | COM | 22,000 | $818.0K | 0.6% | +4,000+22.2% | Added | History |
| ARVNArvinas, Inc. | COM | 15,000 | $617.4K | 0.5% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $526.2K | 0.4% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $490.0K | 0.4% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 10,000 | $460.6K | 0.4% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 321,200 | $443.3K | 0.3% | −134,000−29.4% | Reduced | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 469,832 | $406.4K | 0.3% | −102,000−17.8% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 28,000 | $397.3K | 0.3% | 00.0% | Unchanged | History |
| HALOHalozyme Therapeutics, Inc. | COM | 10,000 | $369.6K | 0.3% | 00.0% | Unchanged | History |
| CHRSCoherus Oncology, Inc. | COM | 110,000 | $366.3K | 0.3% | +110,000 | New | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 10,000 | $365.0K | 0.3% | +10,000 | New | History |
| BHVNBiohaven Ltd. | COM | 7,365 | $315.2K | 0.2% | +7,365 | New | History |
| KROSKeros Therapeutics, Inc. | COM | 7,000 | $278.3K | 0.2% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 12,300 | $261.1K | 0.2% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 25,114 | $255.9K | 0.2% | 00.0% | Unchanged | History |
| GTHXG1 Therapeutics, Inc. | COM | 80,000 | $244.0K | 0.2% | −40,000−33.3% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 16,000 | $242.4K | 0.2% | +16,000 | New | History |
| SRPTSarepta Therapeutics, Inc. | COM | 2,500 | $241.1K | 0.2% | 00.0% | Unchanged | History |
| LQDALiquidia Corp | COM NEW | 20,000 | $240.6K | 0.2% | +20,000 | New | History |
| CABACabaletta Bio, Inc. | COM | 10,000 | $227.0K | 0.2% | +10,000 | New | History |
| CSTLCastle Biosciences Inc | COM | 10,000 | $215.8K | 0.2% | +10,000 | New | History |
| WVEWave Life Sciences, Inc. | SHS | 40,000 | $202.0K | 0.2% | +40,000 | New | History |
| GOSSGossamer Bio, Inc. | COM | 138,176 | $126.1K | 0.1% | −70,912−33.9% | Reduced | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $119.8K | 0.1% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 19,833 | $84.7K | 0.1% | −40,000−66.9% | Reduced | History |
| IFRXInflaRx N.V. | COM | 50,000 | $81.5K | 0.1% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 28,800 | $71.1K | 0.1% | +2,400+9.1% | Added | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,750 | $4.49K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2023 (1)
Positions held at the end of Q3 2023 that are gone from this filing.